Benitec Biopharma Inc (BNTC)
9.23
+0.44
(+5.01%)
USD |
NASDAQ |
Sep 27, 16:00
9.025
-0.20
(-2.22%)
After-Hours: 20:00
Benitec Biopharma Cash from Financing (Quarterly): 40.07M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 40.07M |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.039M |
September 30, 2023 | 27.92M |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 16.02M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 12.67M |
March 31, 2021 | 0.003M |
December 31, 2020 | 9.851M |
September 30, 2020 | |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Date | Value |
---|---|
December 31, 2019 | 0.00 |
September 30, 2019 | 1.77M |
June 30, 2019 | 0.00 |
March 31, 2019 | |
December 31, 2018 | 0.0144M |
September 30, 2018 | -0.0144M |
June 30, 2018 | 6.249M |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.0258M |
March 31, 2017 | 4.271M |
December 31, 2016 | 1.804M |
September 30, 2016 | 0.00 |
June 30, 2016 | -0.3331M |
March 31, 2016 | 0.6602M |
December 31, 2015 | 0.5235M |
September 30, 2015 | 12.23M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
40.07M
Maximum
Jun 2024
5.702M
Average
--
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.492M |
Palatin Technologies Inc | 9.136M |
iBio Inc | 12.99M |
Theriva Biologics Inc | 1.773M |
Oragenics Inc | 0.8212M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.293M |
Free Cash Flow | -19.58M |
Free Cash Flow Per Share (Quarterly) | -0.3265 |
Free Cash Flow Yield | -48.67% |